Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026)
Zimmer Biomet Holdings (ZBH) posted Income from Non-Controlling Interests of $1.3 million for Q2 2026, up 550.0% on a QoQ basis from $200000.0 in Q1 2026, and up 116.67% year-over-year from $600000.0 in Q2 2025.
Powered by 
Analysis
Zimmer Biomet Holdings (ZBH) Income from Non-Controlling Interests (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Income from Non-Controlling Interests for 16 years, with the latest figure at $1.3 million in Q2 2026.
- On a quarterly basis, Income from Non-Controlling Interests rose 116.67% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $300000.0, a 85.71% decrease from a year earlier, with the FY2025 full-year figure at -$100000.0, down 106.67% from the prior year.
- Income from Non-Controlling Interests was $1.3 million for Q2 2026 at Zimmer Biomet Holdings, up from $200000.0 in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $1.3 million in Q2 2026, with the low at -$1.5 million in Q4 2025.
- Average Income from Non-Controlling Interests over 5 years is $288888.9, with a median of $300000.0 recorded in 2022.
- The sharpest annual moves came in 2022 and 2025: Income from Non-Controlling Interests soared 200.0% in 2022, then slumped 314.29% in 2025.
- Over 5 years, Income from Non-Controlling Interests stood at $300000.0 in 2022, then surged by 66.67% to $500000.0 in 2023, then soared by 40.0% to $700000.0 in 2024, then sank by 314.29% to -$1.5 million in 2025, then jumped by 186.67% to $1.3 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at $1.3 million (Q2 2026), $200000.0 (Q1 2026), and -$1.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 6.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -2.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -500,000.00 |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 900,000.00 |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 1.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.30 Mn |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | -1.50 Mn |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 600,000.00 |
| Dec 31, 2024 | 700,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 200,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 200,000.00 |